• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

SPR Therapeutics

edit

SPR® Therapeutics is a medical device company that is commercializing pain treatments utilizing its proprietary peripheral nerve stimulation (PNS) products. We are developing a pipeline of neurostimulation pain therapies that will exploit the same physiologic mechanism of action, proprietary technology, and clinical approach. The first product to be commercialized is the SMARTPATCH™ PNS System, which is a short-term, minimally invasive system that is simple to deliver and can be used for up to 30 days to stimulate electrically a peripheral nerve to relieve pain.

Recent Milestones

edit

• 
  SPR Therapeutics received $5M in Series A funding. (1/8/13)
  Posted 1/8/13 at 6:39pm via finsmes.com
• 
  SPR Therapeutics received $250k in Venture Round funding. (4/27/11)
  Posted 4/28/11 at 5:46pm via finsmes.com
• 
  SPR Therapeutics added Maria E. Bennett as CEO.
  Posted 4/28/11 at 5:46pm
• 
  SPR Therapeutics added Julie Grill as Vice President of Regulatory Affairs and Quality Systems.
  Posted 1/10/13 at 5:47am
• 
  SPR Therapeutics added Mark Stultz as Vice President of Market Development.
  Posted 1/10/13 at 5:47am

Videos

Screenshots

edit

Sources

1. SPR Therapeutics Recieves $250K from JumpStart Ventures (finsmes.com) [edit]
2. SPR Therapeutics Raises $5M in Series A Financing (finsmes.com) [edit]